Identification of the gene variations in human CD22

Immunogenetics

Volumn 49, Issue 4, 1999, Pages 280-286

  Hatta, Yoko ^a   Tsuchiya, Naoyuki ^a   Matsushita, Masaki ^a   Shiota, Michiko ^a   Hagiwara, Kiyofumi ^a   Tokunaga, Katsushi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

CD22; Japanese; Polymorphism; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

CD22 ANTIGEN; DNA;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD22; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ARTHRITIS, RHEUMATOID; CELL ADHESION MOLECULES; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LECTINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; VARIATION (GENETICS);

EID: 0344958862     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050494     Document Type: Article

References (33)

1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Shar JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324
2. Bannai M, Tokunaga K, Lin L, Kuwata S, Mazda T, Amaki I, Fujisawa K, Juji T (1994) Discrimination of human HLA-DRB1 alleles by PCR-SSCP (single-strand conformation polymorphism) method. Eur J Immunogenet 21: 1-9
3. Boue DR, Lebien TW (1988) Structural characterization of the human B lymphocyte-restricted differentiation antigen CD22. Comparison with CD21 (complement receptor type 2/Epstein-Barr virus receptor). J Immunol 140: 192-199
4. Campbell MA, Klinman NR (1995) Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur J Immunol 25: 1573-1579
5. Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC (1998) Polygenic autoimmune traits: Lyn, CD22 and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8: 497-508
6. Cyster JG (1997) Signaling thresholds and interclonal competition in preimmune B-cell selection. Immunol Rev 156: 87-101
7. Cyster JG, Goodnow CC (1997) Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 6: 509-517
8. Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT (1995) A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269: 242-244
9. Engel P, Wagner N, Miller AS, Tedder TF (1995) Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. J Exp Med 181: 1581-1586
10. Erickson LD, Tygrett LT, Bhatia SK, Grabstein KH, Waldschmidt TJ (1996) Differential expression of CD22 (Lyb8) on murine B cells. Int Immunol 8: 1121-1129
11. Hibbs ML, Tarlinton DM, Armes J, Hodgson G, Maglitto R, Stacker SA, Dunn AR (1995) Multiple defects in the immune system of lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311
12. Imanishi T, Akaza A, Kimura A, Tokunaga K, Gojobori T (1992) Estimation of allele and haplotype frequencies for HLA and complement loci. In: Tsuji M, Aizawa M, Sasazuki T (eds) HLA 1991, vol 1. Oxford University Press, Oxford, pp 76-79
13. Klinman DM (1997) B-cell abnormalities characteristics of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois' lupus erythematosus, 5th edn. Williams & Wilkins, Baltimore, pp 195-206
14. Law CL, Torres RM, Sundberg HA, Parkhouse RM, Brannan CI, Copeland NG, Jenkins NA, Clark EA (1993) Organization of the murine Cd22 locus. Mapping to chromosome 7 and characterization of two alleles. J Immunol 151: 175-187
15. Law CL, Sidorenko SP, Clark EA (1994) Regulation of lymphocyte activation by the cell-surface molecule CD22. Immunol Today 15: 442-449
16. Nadler MJ, McLean PA, Neel BG, Wortis HH (1997) B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines. J Immunol 159: 4233-4243
17. Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC (1997) CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 7: 133-143
18. O'Keefe TL, Williams GT, Davies SL, Neuberger MS (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274: 798-801
19. Otipoby KL, Andersson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perlmutter RM, Law CL, Clark EA (1996) CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384: 634-637
20. Pleiman CM, Hertz WM, Cambier JC (1994) Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263: 1609-1612
21. Powell LD, Jain RK, Matta KL, Sabesan S, Varki A (1995) Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding. J Biol Chem 270: 7523-7532
22. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang ML, Tedder TF (1996) CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5: 551-562
23. Schwartz-Albiez R, Dorken B, Monner DA, Moldenhauer G (1991) CD22 antigen: biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion. Int Immunol 3: 623-633
24. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277
25. Tedder TF, Tuscano J, Sato S, Kehrl JH (1997) CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol: 481-504
26. Tokunaga K, Imanishi T, Takahashi K, Juji T (1996) On the origin and dispersal of East Asian populations as viewed from HLA haplotypes. In: Akazawa T, Szathmary EJ (eds) Prehistoric mongoloid dispersals. Oxford University Press, Oxford, pp 187-197
27. Tsuchiya N, Shiota M, Moriyama S, Ogawa A, Komatsu-Wakui M, Mitsui H, Geraghty DE, Tokunaga K (1998) MICA allele typing of HLA-B27 positive Japanese patients with seronegative spondylarthropathies and healthy individuals: differential linkage disequilibrium with HLA-B27 subtypes. Arthritis Rheum 41: 68-73
28. Tsui HW, Siminovitch KA, de Souza L, Tsui FW (1993) Motheaten and viable motheaten mice have mutations in the the haematopoietic cell phosphatase gene. Nat Genet 4: 124-129
29. Tuscano JM, Engel P, Tedder TF, Agarwal A., Kehrl JH (1996) Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22. Eur J Immunol 26: 1246-1252
30. van der Merwe PA, Crocker PR, Vinson M, Barclay AN, Schauer R, Kelm, S (1996) Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J Biol Chem 271: 9273-9280
31. Vyse TJ, Todd JA (1996) Genetic analysis of autoimmune disease. Cell 85: 311-318
32. Wicker LS, Todd JA, Peterson LB (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13: 179-200
33. Wilson GL, Najfeld V, Kozlow E, Menniger J, Ward D, Kehrl JH (1993) Genomic structure and chromosomal mapping of the human CD22 gene. J Immunol 150: 5013-5024